Use of acetylsalicylic acid, expression of pre-eclâmpsia markers and doppler of uterine arteries in the second gestational trimester
DOI:
https://doi.org/10.33448/rsd-v14i10.49706Keywords:
AAS, Prediction, Preeclampsia.Abstract
Preeclampsia (PE) occurs during pregnancy with hypertension and proteinuria and is associated with maternal and fetal morbidity and mortality. In the pathophysiology, there is a vascular and placental inflammatory dysfunction, altering serum and biophysical markers. Acetylsalicylic acid (ASA) can prevent the disease by reducing the inflammatory process. Thus, the aim of this study was to analyze whether the use of ASA interferes with the Doppler of the uterine arteries and serum markers of PE in pregnant women. This was a cross-sectional study involving 71 pregnant women between 20 and 24 weeks and 6 days of gestation, in maternity hospitals in Rio Grande do Norte. Questionnaires were applied to characterize the population; morphological ultrasound was performed in the 2nd trimester with Doppler evaluation of the uterine arteries and measurement of serum levels of PlGF (Placental Growth Factor). The data were tabulated in SPSS (Statistical Package for the Social Sciences – version 4.2.2) for descriptive analysis and Spearman correlation. The mean body mass index (BMI) of the sample was 31.02. Thirty-eight pregnant women confirmed the use of AAS and in this group the mean values of the pulsatility index (PI) of the uterine arteries were 1.03 and of the PlGF 307.80, and in those who did not use, the values were 0.95 and 325.3, respectively. In this study, the use of AAS did not contribute to the reduction of the PI of the uterine arteries and there was no significant difference in the mean of the PIGF. Larger studies are important to confirm these results.
References
Adibrata, M A; Sulistyono, A; & Ernawati. A. (2018). Role of aspirin dose in reducing uterine artery resistance in 16-24 weeks pregnant women with abnormal uterine artery resistance. Maj Obs Gin, Vol. 26 No. 3 December 2018 : 128-134
Antiwi, E. (2022). Systematic review of prediction models for gestational hypertension and preeclampsia, Supervision, Writing – review & editing, and Kerstin Klipstein-Grobusch, Formal analysis, Supervision, Writing – review & editing, 2022. V. 4.
Cecatti ,J G, Costa Ecatti, M L, Haddad, S M, Parpinelli, M A, & Souza, J P, (2016). Network for Surveillance of Severe Maternal Morbidity: a powerful national collaboration generating data on maternal health outcomes and care. BJOG : an international journal of obstetrics and gynaecology.; 2016, 123(6):946-53.
COBAS, (2023). Ensaio Elecsys PlGF COBAS. 2023. N. 1.
Dimitriadis E; Rolnik D L; Zhou W; Estrada-Gutierrez; Koga K; Francisco R P V; Whitehead C; Hyett J; Costa F S; & Nicolaides K. (2023). Pre-Eclampsia. Nature Reviews Disease Primers.
Dimitriadis, E; Rolnik, D L et al. (2023). Pre-eclampsia. Nature Reviews Disease Priemes. v.9. 2023
Horgan, R; Diab, Y H; Walle,r J; Abuhamad, A; & Saade, G. (2023). Low Dose Aspirin Therapy for the Prevention of Preeclampsia: Time to Reconsider our Recommendations? 2023. American Journal of Obstetrics and Gynecology.
ISUOG - (2021). International Society of Ultrasound in Obstetrics and Gynecology . Practice Guidelines (updated): use of Doppler velocimetry in obstetrics. Ultrasound Obstet Gynecol 2021, N. 33.
ISUOG (2018). Practice Guidelines: role of ultrasound inscreening for and follow-up of pre-eclampsia. 2018. Ultrasound Obstet Gynecol.
Khong, S L, & Kane, S C, (2015). Brenneck SPFirst-Trimester Uterine Artery Doppler Analysis in the Prediction of Later Pregnancy Complications. Disease Markers, [S.L.], v. 2015, p. 1-10,
Khong, S L, Kane, S C, & Brenneck, S P. (2015). First-Trimester Uterine Artery Doppler Analysis in the Prediction of Later pregnancy Complications. Disease Markers Volume Article ID 679730, 2015 10 pages.
Langley‐Evans, S C, Pearce, J, & Ellis, S. (2022). Overweight, obesity and excessive weight gain in pregnancy as risk factors for adverse pregnancy outcomes: A narrative review. 2022. Journal of Human Nutrition and Dietetics. doi: 10.1111/jhn.12999
Loardi, C, Fratelli, N, Mazzoni, G, & Orabona, R. (2021). Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy. Pregnancy Hypertension Available online, 2021 16 September
Lopez, O, Rosario ,G, Gutierrez, M, & Mauricio, L. (2015). Características epidemiológicas y obstétricas de las mujeres diagnosticadas con preeclampsia grave en sala de Alto Riesgo Obstétrico Hospital Carlos Roberto Huembes Enero- Diciembre 2014. Other thesis, Universidad Nacional Autónoma de Nicaragua, 2015. Managua.
Mello, A B Q B, & Nunes, C P. (2019). Rastreamento de pré-eclâmpsia: novas perspectivas. Revista de Medicina de Família e Saúde Mental, 2019, Vol. 1. Nº2.
Murtoniemi, K.; Vahlberg, T , Hämäläinen, E, Kajantie; Pesonen; Räikkönen, K; Taipale, P; Villa, P M; & Laivuori, H. (2018). The effect of low-dose aspirin on serum placental growth factor levels in a high-risk PREDO cohort. 2018. Pregnancy Hypertension.
Peraçoli, J C, Costa, M L, Cavalli, R C, de Oliveira, L G, Korkes, H A, Ramos, J G L, Martins-Costa, S H, de Sousa, F L P, Cunha Filho, E V, & Mesquita, M R S.. (2023). Pre-clâmpsia, Protocolo 2023. Rede Brasileira de Estudos sobre Hipertensão na Gravidez.
Permatasari, D I; Triawanti; Yunanto, A; & Arifin, S. (2023). The Relationship of Age and Obesity with The Event of Preeclampsia in Pregnant Women. Jurnal Berkala Kesehatan. 2023; 9(1): 1-9
Rastrepo, F H, Hernandez, F, Perrila, N, & Sanchez, L M. (2017). Biomarcadores moleculares: una nueva herramienta en el diagnóstico de la preeclampsia. Clínica e Investigación en Ginecología y Obstetricia, 2017 Volume 44, Issue 2, April–June, Pages 66-72
Roberge, S; Bujold, E; & Nicolaides, K H. (2018). Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. 2018. American Journal of Obstetrics & Gynecology.
Rodriguez, M, Couve-perez, C, S A N Martin, S, Martinez, F, & Lozano, C. (2018). Perinatal outcome and placental apoptosis in patients with late-onset pre-eclampsia and abnormal uterine artery Doppler at diagnosis. Ultrasound Obstet Gynecol.; 2018, 51(6):775-82.
Rolnik, D L; Syngelaki, A; Neil O’Gorman; Wrigh,t D; Poon, L C; Kypros, H. & Nicolaides. (2023). ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. 2023. Ultrasound Obstetrics and Gynecology.
Rolnik, D L, Syngelaki, A, O’Gorman, N, & Wright, D. (2023). ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. Ultrasound Obstet Gynecol; 2023. 61: 691–697.
Rolnik, D L; Nicolaides, K H; & Poon, L C. (2020). Prevention of preeclampsia with aspirin, 2020. American Journal of Obstetrics & Gynecology.
Sá, C P N, Jiménez, M F, Wengrover ,M, & Arlindo, E M. (2022). Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis Rev Bras Ginecol Obstet 2020; 42(11):697–704.
Sharma, N; Srinivasan, S; Jayashree, K. S; & Nadhamuni, K. (2017). Role of Aspirin in High Pulsatility Index of Uterine Artery: A Consort Study. 2017. The Journal of Obstetrics and Gynecology of India.
Sousa, Á. (2019). Coeficiente de correlação de Pearson e coeficiente de correlação de Spearman. O que medem e em que situações devem ser utilizados?. «Correio dos Açores: Matemática», 21 de Março de 2019, p. 19.
Stepan, H, Galindo, A, Hund ,M, et.al. (2023). Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol 2023; 61: 168–180
Vieira ,M C; Poston, L; Fyfe, E; Gillet, A; Kenny, L C; Robert, C T; Baker, P N; Myers, J E; Walker, J J; McCowan, L M; North, R A, & Pasupathy,
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Bianca Caroline da Cunha Germano, Brismark Goes da Rocha, Juliana Dantas de Araújo Santos Camargo, Dany Geraldo Kramer, Ricardo Ney Oliveira Cobucci
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
